Skip to search.
 FTSE 100 Down 0.71%

Sarepta Therapeutics, Inc. (SRPT)

-NasdaqGS
13.63 Down 0.45(3.20%) 6 Mar 21:00
|After Hours: : 13.72 Up 0.09 (0.66%) 00:16
Add to Portfolio
Prev Close:14.08
Open:14.00
Bid:13.53 x 200
Ask:13.90 x 600
1y Target Est:25.31
Beta:1.75
Earnings Date:6 May - 11 May (Est.)
Day's Range:13.51 - 14.09
52wk Range:11.33 - 40.00
Volume:530,412
Avg Vol (3m):995,970
Market Cap:563.07m
P/E (ttm):N/A
EPS (ttm):-3.39
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SRPTDown 3.20%563.07m
ALNYDown 3.49%9.02b
GSKDown 1.83%112.41b
ISISDown 1.84%8.38b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):59.61
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-4.21
Quarterly EPS Est (Mar-15) :-1.00
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):16.70

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare and infectious diseases. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback